Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ARHGAP33 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-10 |
mRNA | RFXAP | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-10 |
mRNA | NISCH | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-10 |
mRNA | ILF3 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-10 |
mRNA | ZNF84 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-10 |
mRNA | SMARCC1 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-10 |
mRNA | GPC2 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-10 |
mRNA | ADNP2 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
mRNA | PRPF38A | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | KCNH3 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |